Open AccessPosted Content
Methods for the Economic Evaluation of Health Care Programmes
Reads0
Chats0
TLDR
The fourth edition of the Methods for the Economic Evaluation of Health Care Programmes as mentioned in this paper has been thoroughly revised and updated, making it essential reading for anyone commissioning, undertaking, or using economic evaluations in health care, including health service professionals, health economists, and health care decision makers.Abstract:
The purpose of economic evaluation is to inform decisions intended to improve healthcare. The new edition of Methods for the Economic Evaluation of Health Care Programmes equips the reader with the necessary tools and understanding required to undertake evaluations by providing an outline of key principles and a 'tool kit' based on the authors' own experiences of undertaking economic evaluations. Building on the strength of the previous edition, the accessible writing style ensures the text is key reading for the non-expert reader, as no prior knowledge of economics is required. The book employs a critical appraisal framework, which is useful both to researchers conducting studies and to decision-makers assessing them. Practical examples are provided throughout to aid learning and understanding. The book discusses the analytical and policy challenges that face health systems in seeking to allocate resources efficiently and fairly. New chapters include 'Principles of economic evaluation' and 'Making decisions in healthcare' which introduces the reader to core issues and questions about resource allocation, and provides an understanding of the fundamental principles which guide decision making. A key part of evidence-based decision making is the analysis of all the relevant evidence to make informed decisions and policy. The new chapter 'Identifying, synthesising and analysing evidence' highlights the importance of systematic review, and how and why these methods are used. As methods of analysis continue to develop, the chapter on 'Characterising, reporting and interpreting uncertainty' introduces the reader to recent methods of analysis and why characterizing uncertainty matters for health care decisions. The fourth edition of Methods for the Economic Evaluation of Health Care Programmes has been thoroughly revised and updated, making it essential reading for anyone commissioning, undertaking, or using economic evaluations in health care, including health service professionals, health economists, and health care decision makers.read more
Citations
More filters
Journal ArticleDOI
Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan
TL;DR: This study reaffirms the differences in health-related preference values across countries and indicates that the high proportion of negative values might indicate that it has also partially measured the intensity of fear in addition to the utility of different health states.
Journal ArticleDOI
Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders.
Christian Brettschneider,Hans-Helmut König,Wolfgang Herzog,Claudia Kaufmann,Rainer Schaefert,Alexander Konnopka +5 more
TL;DR: The EQ-5D showed a considerable validity and a limited responsiveness in patients with somatoform disorders and was evaluated by comparison with a general population sample and by the ability to distinguish between different symptom severities.
Journal ArticleDOI
Median-Based Incremental Cost-Effectiveness Ratio (ICER).
Heejung Bang,Hongwei Zhao +1 more
TL;DR: It is suggested that mean- and median-based ICERs be considered together as complementary tools in CEA for informed decision making, acknowledging the pros and cons of each.
Journal ArticleDOI
The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.
Janneke P.C. Grutters,Madelon Pijls-Johannesma,Dirk De Ruysscher,Andrea Peeters,Stefan Reimoser,Johan L. Severens,Johan L. Severens,Philippe Lambin,Manuela A. Joore,Manuela A. Joore +9 more
TL;DR: It is recommended not to adopt particle therapy as standard treatment in NSCLC yet, and more evidence is needed to reduce the decision uncertainty and to support evidence-based treatment decisions.
Journal ArticleDOI
A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma: a prospective randomised phase III study
M van Agthoven,C.M. Segeren,I. Buijt,C.A. Uyl-de Groot,B. van der Holt,Henk M. Lokhorst,Pieter Sonneveld +6 more
TL;DR: Cost-effectiveness of myeloma therapy after 3 years of follow up seems not to be favoured by myeloablative treatment with autologous stem-cell rescue, and intensive chemotherapy is regarded as standard therapy for younger patients with previously untreated MM.